Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Environment
Re: Nano drug delivery
June 27, 2016
| A version of this story appeared in
Volume 94, Issue 26
“Does Nanomedicine Have a Delivery Problem?” (C&EN, June 20, page 16), which surveyed the state of cancer nanomedicines’ delivery efficiencies, piqued readers’ interest.
▸ cenm.ag/nanodelivery
Short answer [to the story’s headline]: YES! This is the holy grail pursuit of our time.
Carolyn Bertozzi (@CarolynBertozzi) via Twitter
Great article. Critical reviews that highlight shortcomings and challenges in a field instead of only the advances are the most educational in my opinion.
David McLeod via Facebook
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter